fostamatinib
fostamatinib: 4 clinical trials tracked.
fostamatinib evidence translation
What we can confirm
4 tracked trials
What it means
What to watch
Prepared research question
What is verified about fostamatinib, and what remains unknown?
Traceable citations · Unknowns marked
See linked entities and source evidence3 indications · 0 study sponsors
Study sponsors
No additional listed-company sponsor is linked.
Clinical Trial Registry Records (4)
Randomized, Double-Blinded, Placebo-Controlled Phase 2 Study for the Long Term Evaluation of Fostamatinib for the Treatment of Adult Patients With Acute Respiratory Distress Syndrome (ARDS)
Primary endpoint: Cumulative Incidence of Serious Adverse Events (SAEs) Through Day 30
Syk Inhibition in MItigating Lung Allograft Rejection (SIMILAR): A Phase 1, Double-Blind, Randomized, Placebo-Controlled, Dose Escalation Trial to Evaluate the Safety and Tolerability of Fostamatinib in Lung Transplant Patients With Donor-Specific Antibodies.
Primary endpoint: Study Drug Discontinuation Rate.
Phase I Trial of Ruxolitinib Plus Fostamatinib for the Treatment of Steroid Refractory Chronic Graft Versus Host Disease
Primary endpoint: Minimum safe and biologically effective dose
Randomised Multi-arm Trial of Ruxolitinib (RUX) and Fostamatinib (FOS) for COVID-19 Pneumonia
Primary endpoint: Progression from mild to severe COVID-19 pneumonia within 14 days in hospitalised patients